Theodore Zucconi, president of Pro-Pharmaceuticals, said: “This financing, together with the ‘friends and family’ private placement we recently completed, enables us to reach critical milestones for Davanat and our fibrosis compounds.”
Theodore Zucconi, president of Pro-Pharmaceuticals, said: “This financing, together with the ‘friends and family’ private placement we recently completed, enables us to reach critical milestones for Davanat and our fibrosis compounds.”